CHELSEA DRISCOLL: Open Payments
NPI 1457830465 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,797 in 121 payments from 20 companies in 2025. Trend: 2023 $502 · 2024 $1,044 · 2025 $1,797
Food & beverage: $1,797
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $406 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $239 |
| Lundbeck LLC | 17 | $198 |
| PFIZER INC. | 9 | $189 |
| Axsome Therapeutics, Inc. | 13 | $165 |
| Alkermes, Inc. | 9 | $140 |
| Otsuka America Pharmaceutical, Inc. | 3 | $80 |
| Vanda Pharmaceuticals Inc. | 4 | $75 |
| Indivior Inc. | 3 | $66 |
| GlaxoSmithKline, LLC. | 2 | $37 |
Products named: REXULTI, CAPLYTA, VRAYLAR, Auvelity, NURTEC ODT, ARISTADA, MAVYRET, FANAPT.
Industry payments across IN — which companies pay providers there.
